Taken together, these findings suggest that ELAVL3 is an important RBP in ALS pathogenesis acquired early and the neuropathological data suggest that it is involved by loss of function rather than cytoplasmic toxicity. The gene discussed is ELAVL3; the disease is amyotrophic lateral sclerosis.